Brain metastases represent a growing healthcare challenge with a rising incidence attributed to earlier detection and improved systemic cancer treatments. We conducted a systematic review and meta-analysis to investigate the local recurrence rate following surgical resection of a brain metastasis without adjuvant therapy. The analysis included four studies with a total of 235 cases. It was found that the rate of local recurrence by 12-months was 48.1% (95% CI 41.2-58.9). These findings underscore the high rate of patients who will experience local recurrence within 12-months of surgery, emphasising the need for vigilant surveillance when omitting adjuvant radiotherapy in favour of systemic treatments with potential but unproven CNS penetrance. The analysis highlights unmet needs in this patient population.
Keyphrases
- healthcare
- free survival
- brain metastases
- early stage
- small cell lung cancer
- white matter
- public health
- minimally invasive
- resting state
- risk factors
- radiation therapy
- multiple sclerosis
- squamous cell carcinoma
- case report
- papillary thyroid
- coronary artery bypass
- cerebral ischemia
- acute coronary syndrome
- brain injury
- social media
- percutaneous coronary intervention
- squamous cell
- label free